Home Products Most Popular Contact
No items in your cart.
The page below is a sample from the LabCE course Hereditary Hemochromatosis. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Hereditary Hemochromatosis (online CE course) »
How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 123 CE courses, most popular
$95 Add to cart
Pick Your Courses
Up to 8 CE hours
$50 Add to cart
Individual course$20 Add to cart

Other Treatments

Deferoxamine (DFO), an iron chelating agent, may be used to reduce iron overload in patients for whom phlebotomy is contraindicated or not well tolerated. Examples include patients with sickle cell disease or thalassemia whose anemia would be exacerbated by phlebotomies. DFO is seldom used to treat HH due to the low cost and efficacy of phlebotomy therapy, but may be used for HH patients who can't tolerate frequent phlebotomies. DFO is typically administered by intravenous or subcutaneous infusion.
Patients with HH may be counseled to avoid alcohol use in order to minimize the potential for liver damage. With the exception of iron supplements, dietary restrictions on iron ingestion are rarely advised.